CGC - Canopy Growth Corporation

NYSE - NYSE Delayed Price. Currency in USD
27.46
+0.93 (+3.51%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close26.53
Open26.75
Bid27.41 x 1200
Ask27.50 x 1100
Day's Range26.54 - 27.48
52 Week Range22.76 - 59.25
Volume2,536,718
Avg. Volume4,687,087
Market Cap9.576B
Beta (3Y Monthly)3.68
PE Ratio (TTM)N/A
EPS (TTM)-1.79
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga

    The Week In Cannabis: Big Pharma Makes Moves, Diddy & Wahlberg Go After CBD, Medicine Man Continues M&A Spree

    This week, we saw Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) make a big move in the cannabis industry, through a distribution deal between its subsidiary Salomon, Levin, Elstein, and InterCure Ltd ...

  • PR Newswire

    Benzinga Cannabis' Javier Hasse To Speak At Major Events In The U.S., Jamaica, Argentina

    In the coming weeks Benzinga Cannabis' managing director Javier Hasse will be touring the Americas, speaking at four major cannabis conferences. DETROIT, Sept. 13, 2019 /PRNewswire/ -- Benzinga, a financial technology company centered on delivering actionable trading insights, is announcing its managing director for cannabis, Javier Hasse, will be touring the Americas and speaking at four major cannabis conferences in upcoming weeks. Below is a list of major speaking engagements.

  • Cannabis companies have secret formulas to determine when the U.S. may allow pot sales
    MarketWatch

    Cannabis companies have secret formulas to determine when the U.S. may allow pot sales

    The two largest pot companies in the world have developed secret formulas that predicts U.S. federal and state cannabis legalization.

  • Aurora Cannabis CCO on missing company's own revenue estimates: We're 'a little red-faced'
    Yahoo Finance

    Aurora Cannabis CCO on missing company's own revenue estimates: We're 'a little red-faced'

    Aurora Cannabis missed its own revenue estimates for the fourth quarter, but Chief Corporate Officer Cam Battley explains why it wasn't all bad news.

  • Benzinga

    Canopy Rivers Explains Its Investments, Atypical Financial Reporting

    Its objective is clear, though: to create value for shareholders by making investments in the global cannabis sector. Canopy Growth Corp (NYSE: CGC) is Canopy Rivers’ biggest shareholder, with a 27% stake.

  • Medical Cannabis: A Hot Topic at Events Across the World
    Market Realist

    Medical Cannabis: A Hot Topic at Events Across the World

    These days, experts are discussing the pros and cons of medical cannabis at multiple conferences and summits around the world.

  • Benzinga

    Meet Canopy Rivers' New Strategic Advisory Board

    Canopy Rivers Inc (OTC: CNPOF ) (TSX: RIV), a venture capital firm specializing in cannabis, which counts Canopy Growth Corp (NYSE: CGC ) as its largest investor, announced this week the first three members ...

  • Aurora Cannabis: Are Its Q4 Results Good or Bad News?
    Market Realist

    Aurora Cannabis: Are Its Q4 Results Good or Bad News?

    Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?

  • Aurora Cannabis Slides On Sales Miss, Even As New Facilities Help Production
    Investor's Business Daily

    Aurora Cannabis Slides On Sales Miss, Even As New Facilities Help Production

    Canadian pot producer Aurora Cannabis reported fiscal fourth-quarter sales after the close Wednesday that missed the company's own estimates, sending shares into retreat.

  • Aurora Cannabis Stock Still Eyeing $8
    InvestorPlace

    Aurora Cannabis Stock Still Eyeing $8

    A few weeks ago I shared an opinion on Aurora Cannabis (NYSE:ACB) stock when it had upside potential. The celebration was short since after a just a brief pop, the whole cannabis sector fell apart in heavy selling. ACB, Canopy Growth (NYSE:CGC), Cronos (NYSE:CRON), and ETFMG Alternative Harvest ETF (NYSEARCA:MJ) stocks all fell 10% to 20% in a matter of hours.Needless to say, consequently, the ACB stock bulls left a $3 potential spike on the table. The good news is that they have since found footing and now again there is another upside opportunity in the making.The pot stocks are still in the process of recovering the losses. Aurora Cannabis stock looks relatively strong among them in this effort. Even with its recent misfortunes, Aurora Cannabis stock is still up 21% year-to-date. So a few bad days on a chart don't necessarily kill the whole story of a stock.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Sell in Market-Cursed September In my last Aurora Cannabis stock write-up, I also noted that equities in general were headed into geopolitical headline hell, so it was a risky trade at the time. The idea was that ACB had support below $6 per share so that the bulls had a solid base from which to spring.The good news is that this latest test proved that support held. In spite of resistance above, there should be another attempt at a rally in ACB stock even from here. Aurora Cannabis Stock Still Eyeing $8For almost four months, Aurora Cannabis stock has slid inside a descending channel of lower highs and lower lows. This last dip from mid-August may have forced the issue because it formed a short-term bottom.If so, then all the ACB bulls need to do is maintain a series of higher highs to close above $6.4 per share. Then they would retake the reins and have the opportunity to finally breakout from the descending trend. The result would be the opportunity to target $8 per share or higher. Aurora Cannabis is a momentum stock so it runs fast enough that they could plow through resistance.I caution against heavy conviction in this trade. The fundamentals for ACB and the entire sector are horrendous. ACB stock sells at 140 times sales so it is very bloated from the traditional sense. Unless the investor knows otherwise, I treat this like a trade and not an investment and set tight stops.The important levels below are between $5.9 and $5.6 per share. Below that and ACB could easily lose another dollar, so traders need to be nimble on bad days. Because just like there is upside potential to $8, there is downside risk to $5 or lower.The mid-term technical oscillators and price-to-moving-averages relationships support the theory that there is an upswing in momentum brewing: One that could fuel this rally in Aurora Cannabis stock. Experts in the field remain unanimous in their optimism.But again I caution about the nature of the opportunity. This is a speculative stock. Unless the timeline is long for the bet, traders need to be spry and aware of the levels. Bottom Line on ACB StockThese are risky stocks. This is nothing against ACB, but this industry didn't even exist just mere months ago. Furthermore, it is still illegal in the United States. Yes, there are states that have legalized marijuana but the federal government still has not followed suit.The enthusiasm on Wall Street for these stocks stems from the wide application for cannabis. Recreational use is already popular but investors' interests extend far beyond that. Companies from all industries are interested in cannabis including the medical, cosmetics, dermatology, beverage, food, and many more industries. It's only a matter of time before it finds its way to retail store shelves.Long term, the game changer source of optimism will probably be a favorable change in U.S. federal law. Imagine what ACB stock and its brethren would do if the U.S. follows Canada and legalizes cannabis nationwide.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. Join his live chat room for free here. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post Aurora Cannabis Stock Still Eyeing $8 appeared first on InvestorPlace.

  • Benzinga

    14 Top Cannabis Stocks Targeted By Short Sellers

    After a weak couple of months, cannabis stocks rallied in the first week of September . That rally seems to have stalled so far in the second week of the month. S3 Partners analyst Ihor Dusaniwsy said ...

  • Why Does Jim Cramer Like Cronos Group and Aphria?
    Market Realist

    Why Does Jim Cramer Like Cronos Group and Aphria?

    Cronos Group and Aphria are Jim Cramer's top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors' faith in the sector.

  • Aurora Cannabis: Investors Are Optimistic about Q4 Earnings
    Market Realist

    Aurora Cannabis: Investors Are Optimistic about Q4 Earnings

    Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.

  • PR Newswire

    Canopy Rivers Launches Strategic Advisory Board

    TORONTO, Sept. 11, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies. "We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Growth’s remaining CEO talks about pot company’s shake-up, and the search for his replacement
    MarketWatch

    Canopy Growth’s remaining CEO talks about pot company’s shake-up, and the search for his replacement

    Up until very recently Canopy Growth Corp. Chief Executive Mark Zekulin rarely spoke to the news media, relying on the boisterous former co-CEO Bruce Linton to spread the company’s message and communicate with shareholders.

  • Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages
    CNW Group

    Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages

    Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages

  • Bet on the Jockey? What You'll Want to Know About the Top Canadian Pot Stock CEOs
    Motley Fool

    Bet on the Jockey? What You'll Want to Know About the Top Canadian Pot Stock CEOs

    The CEOs of the five biggest Canadian cannabis producers -- and which one looks like the best of the bunch.

  • Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
    Zacks

    Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?

    Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?

  • Are These Marijuana Stocks A Good Buy Now? Look Past The Hype
    Investor's Business Daily

    Are These Marijuana Stocks A Good Buy Now? Look Past The Hype

    Are marijuana stocks on U.S. exchanges a good buy now? The marijuana industry gets a lot of hype, but look past the smoke and analyze pot stocks on their fundamentals and technicals.

  • Is Canopy Growth Stock A Buy Right Now? Here's What Earnings, Charts Show
    Investor's Business Daily

    Is Canopy Growth Stock A Buy Right Now? Here's What Earnings, Charts Show

    Canopy Growth stock has been praised by many analysts. Here’s what chart analysis shows about buying this marijuana stock right now.

  • Millennials invested in some underperforming stocks — Uber, Canopy, Aurora — in August: new data
    Yahoo Finance

    Millennials invested in some underperforming stocks — Uber, Canopy, Aurora — in August: new data

    Talk about a horrendous trade by millennials. Here's new data from online brokerage house TD Ameritrade revealing top stocks bought by millennials in August.

  • Benzinga

    Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week

    Cannabis Countdown: Top 10 Marijuana Industry News Stories of the Week Welcome to the  Cannabis Countdown . In this week’s rendition, we’ll recap and countdown the top 10  marijuana industry news  stories ...

  • 3 Pot Stocks Poised to Win in Canada's Cannabis 2.0 Market
    Motley Fool

    3 Pot Stocks Poised to Win in Canada's Cannabis 2.0 Market

    Cannabis derivative products are on the way in Canada. Here are the most likely winners.